Objectives: At the end of this program, participants should be able to:

1. Appreciate the unique approaches to treating neurofibromatosis patients.

2. Understand differences in treating tumors in neurofibromatosis versus different tumor types.

3. Gain an appreciation of future molecular medicine approaches to neurofibromatosis.

Session date: 
11/08/2017 - 8:30am to 9:30am CST
UCMC J-320
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
David Frim, MD, PhD